BAM vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
BAM
CNS
Investment Advisor Scores
CNS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BAM | CNS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 24.8756 | 18.1159 | CNS |
| PEG Ratio | 0.9423 | 1.3225 | BAM |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 71.6% | 11.1% | BAM |
| Earnings Growth | 272.7% | 0.0% | BAM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 33.7/100 | 43.0/100 | CNS |
| Profit Margin | 71.2% | 28.2% | BAM |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | CNS |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BAM
NeutralMixed signals - no dominant trend phase, RSI 63
CNS
DistributionPrice near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50
Fundamentals Snapshot
| Metric | BAM | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 24.4 | 19.6 |
| Trailing P/E | 18.1 | 22.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | 0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | 0.7% | 0.3% |
| EPS | 2.95 | 3.25 |
| Dividend Yield | 0.04% | 0.04% |